It’s almost time—AbbVie’s dividend is coming on August 14!
After realizing some solid gains on $JNJ (-0,9%) , I felt my portfolio was missing a pharmaceutical company that consistently delivers and grows—in other words, a true quality stock. That’s why the decision to buy AbbVie in April was pretty easy for me.
I come from the pharmaceutical industry myself and know that enormous sums have to be invested every year in research, as well as in facility development and expansion—yet profits skyrocket when new drugs take off and hit the market!
Did you actually know that more than 90% of developed compounds never make it to market? There are countless reasons for this—lack of approvals, pharmaceutical regulations, lack of efficacy. I never cease to be fascinated by the fact that so much money can still be made despite all that. Imagine if your auto repair shop couldn’t fix 90% of the vehicles that came in. The business would probably go bankrupt in no time.
Despite all these problems in the pharmaceutical industry—I’m firmly convinced that AbbVie will remain in my portfolio for a long time to come. Do you have any pharmaceutical stocks you’re deeply convinced about?
*AI-generated image*
